DIANE WRIGHT: Open Payments
NPI 1639725401 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 17 payments from 9 companies in 2025. Trend: 2023 $73 · 2024 $401 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $73 |
| Novo Nordisk Inc | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Lilly USA, LLC | 2 | $40 |
| Sandoz Inc. | 1 | $36 |
| Astellas Pharma US Inc | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: JARDIANCE, Ozempic, MOUNJARO, TRELEGY ELLIPTA, SHINGRIX, Veozah, REXULTI, OTEZLA.
Industry payments across NM — which companies pay providers there.
